Search results

127 items matching your search terms.
Filter the results.
Item type









New items since



Sort by relevance · date (newest first) · alphabetically
JRC hosts a meeting to strengthen its collaboration with the European Food Safety Authority (EFSA) - Apr 10, 2017
JRC hosts a meeting to strengthen its collaboration with the European Food Safety Authority (EFSA)
On 5th April JRC-Ispra hosted a delegation from EFSA to discuss specific topics of common interest in the area of risk assessment related to chemicals.
Understanding nanomaterial toxicity by leveraging mechanistic information on chemicals - Apr 05, 2017
Understanding nanomaterial toxicity by leveraging mechanistic information on chemicals
JRC scientists carried out a study illustrating how the mechanisms of nanomaterial toxicity can be better understood by exploiting the broader body of mechanistic information on chemicals in general.
The pathway from liver injury to liver fibrosis - Apr 04, 2017
The pathway from liver injury to liver fibrosis
JRC scientists have used an Adverse Outcome Pathway approach to explain how some chemicals can potentially cause liver fibrosis in humans in order to support the development of non-animal approaches to chemical safety assessment.
EURL ECVAM is inviting public comments on its draft Recommendation on the use of non-animal approaches for skin sensitisation testing - Mar 31, 2017
EURL ECVAM is inviting public comments on its draft Recommendation on the use of non-animal approaches for skin sensitisation testing
The European Union Reference Laboratory for Alternatives to Animal Testing (EURL ECVAM) is inviting public comments on its latest draft Recommendation concerning the use of non-animal approaches for skin sensitisation testing.
JRC meets with OECD experts to define good practices for in vitro methods - Mar 24, 2017
JRC meets with OECD experts to define good practices for in vitro methods
On the 23rd and 24th of March the JRC's EU Reference Laboratory for Alternatives to Animal Testing (EURL ECVAM) hosted a meeting with OECD experts to discuss the draft of a guidance document on Good In Vitro Method Practice (GIVIMP). This GIVIMP document would serve as a technical guidance on good scientific and quality practices to support the regulatory human safety assessment of chemicals using in vitro methods.
JRC supports the use of stem cells for non-animal approaches to regulatory toxicity assessment - Feb 23, 2017
JRC supports the use of stem cells for non-animal approaches to regulatory toxicity assessment
New publication summarises the outcome of a workshop organised by the European Partnership of Alternatives to Animal Testing (EPAA) on the use of stem cell-derived in vitro test systems in toxicology.
Reducing animal testing through better knowledge sharing - Feb 20, 2017
Reducing animal testing through better knowledge sharing
The JRC has carried out a study of available knowledge on the replacement, reduction and refinement (the 3Rs) of animal procedures used in research and testing to understand how supply of such knowledge can better meet demand. Findings show that although much 3Rs knowledge exists, its sharing can be improved through better coordination, communication and outreach, and by more emphasis on targeted education and training initiatives.
A 21st-century roadmap for biomedical research - Feb 15, 2017
A 21st-century roadmap for biomedical research
JRC scientist contributes to the definition of a 21st-century roadmap for biomedical research which proposes the use of human-specific models and innovative in vitro technologies instead of animals.
JRC hosts the VAC2VAC workshop on validation of non-animal methods for quality control of vaccines - Feb 10, 2017
JRC hosts the VAC2VAC workshop on validation of non-animal methods for quality control of vaccines
The JRC's EU Reference Laboratory for alternatives to animal testing (EURL ECVAM) organised this workshop with VAC2VAC partners from the 30th January to the 1st February 2017 to discuss ways of improving multi-centre validation studies and making use of the data generated for product-specific validation purposes.
How Adverse Outcome Pathways can support computational approaches to predictive toxicology - Feb 03, 2017
How Adverse Outcome Pathways can support computational approaches to predictive toxicology
Scientists from the JRC and eleven collaborating organisations from the EU, Canada and the USA have shared their collective insights on how adverse outcome pathways (AOP) can aid the development and use of computational prediction models for regulatory toxicology.